Bakhu Holdings Corp
Bakhu Holdings, Corp. produces, manufactures, and sells cannabis-related byproducts for medical, food additive, and recreational use. The company was formerly known as Planet Resources, Corp. and changed its name to Bakhu Holdings, Corp. in May 2009. Bakhu Holdings, Corp. was incorporated in 2008 and is headquartered in Long Beach, California.
Bakhu Holdings Corp (BKUH) - Net Assets
Latest net assets as of April 2024: $-10.23 Million USD
Based on the latest financial reports, Bakhu Holdings Corp (BKUH) has net assets worth $-10.23 Million USD as of April 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($519.48K) and total liabilities ($10.75 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-10.23 Million |
| % of Total Assets | -1968.88% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 534.18 |
Bakhu Holdings Corp - Net Assets Trend (2008–2023)
This chart illustrates how Bakhu Holdings Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Bakhu Holdings Corp (2008–2023)
The table below shows the annual net assets of Bakhu Holdings Corp from 2008 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-07-31 | $-9.33 Million | -30.29% |
| 2022-07-31 | $-7.16 Million | -190.32% |
| 2021-07-31 | $-2.47 Million | -487.47% |
| 2020-07-31 | $-419.66K | -177.76% |
| 2019-07-31 | $-151.09K | -1508.52% |
| 2018-07-31 | $-9.39K | +89.24% |
| 2017-07-31 | $-87.33K | -936.51% |
| 2009-07-31 | $10.44K | +131.85% |
| 2008-07-31 | $4.50K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Bakhu Holdings Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4747899100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (July 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $301.30K | % |
| Other Components | $37.85 Million | % |
| Total Equity | $-9.33 Million | 100.00% |
Bakhu Holdings Corp Competitors by Market Cap
The table below lists competitors of Bakhu Holdings Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CHRISTIAN DIOR - Dusseldorf Stock Exchang
DU:DIO
|
$4.48 Million |
|
Creative Medical Technology Holdings Inc
NASDAQ:CELZ
|
$4.48 Million |
|
Hemogenyx Pharmaceuticals Plc
PINK:HOPHF
|
$4.48 Million |
|
High Sierra Technologies Inc
PINK:HSTI
|
$4.48 Million |
|
Photon Energy N.V.
WAR:PEN
|
$4.47 Million |
|
Red Sky Energy Ltd
AU:ROG
|
$4.47 Million |
|
Chamni's Eye PCL
BK:CEYE
|
$4.47 Million |
|
Prismaflex Intl
PA:ALPRI
|
$4.47 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Bakhu Holdings Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -7,157,523 to -9,325,815, a change of -2,168,292.
- Net loss of 10,305,454 reduced equity.
- New share issuances of 30,000 increased equity.
- Other factors increased equity by 8,107,162.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-10.31 Million | -110.5% |
| Share Issuances | $30.00K | +0.32% |
| Other Changes | $8.11 Million | +86.93% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Bakhu Holdings Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-07-31 | $0.02 | $0.02 | x |
| 2009-07-31 | $0.03 | $0.02 | x |
| 2010-07-31 | $-0.11 | $0.02 | x |
| 2016-07-31 | $-0.13 | $0.02 | x |
| 2017-07-31 | $-0.34 | $0.02 | x |
| 2018-07-31 | $0.00 | $0.02 | x |
| 2019-07-31 | $0.00 | $0.02 | x |
| 2020-07-31 | $0.00 | $0.02 | x |
| 2021-07-31 | $-0.01 | $0.02 | x |
| 2022-07-31 | $-0.02 | $0.02 | x |
| 2023-07-31 | $-0.03 | $0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Bakhu Holdings Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-32.41%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -11.04% | 0.00% | 0.00x | 1.76x | $-947.30 |
| 2009 | -345.43% | 0.00% | 0.00x | 1.33x | $-37.11K |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-32.17K |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-26.65K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-48.99K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.83 Million |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-10.64 Million |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.08 Million |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.91 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-4.51 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-9.37 Million |
Industry Comparison
This section compares Bakhu Holdings Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Bakhu Holdings Corp (BKUH) | $-10.23 Million | -11.04% | N/A | $4.48 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |